Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Bernard D Naughton"'
Publikováno v:
Frontiers in Medicine, Vol 11 (2024)
BackgroundFalsified medicines and their international regulation impacts all healthcare sectors and their actors. These regulations aim to strengthen and protect the global pharmaceutical supply chain against falsified medicines. However, an evaluati
Externí odkaz:
https://doaj.org/article/da3b282fe7e54b028e8b328583065dbe
Autor:
Bernard D. Naughton
Publikováno v:
Medicine Access @ Point of Care, Vol 1 (2017)
The EU Falsified Medicines Directive (FMD) mandates the serialisation of prescription-only medicines using a two-dimensional (2D) barcode by pharmaceutical companies and the systematic verification of this 2D barcode in pharmacies. This European dire
Externí odkaz:
https://doaj.org/article/224df4aa7c354da299c33112661b6ad7
Autor:
Bernard D Naughton, Dominic McManus
Publikováno v:
BMJ Global Health
BMJ Global Health, Vol 5, Iss 8 (2020)
BMJ Global Health, Vol 5, Iss 8 (2020)
Substandard and falsified (SF) medicines are a global issue contributing to antimicrobial resistance and causing economic and humanitarian harm. To direct law enforcement efficiently, halt the spread of SF medicines and antimicrobial resistance, acad
Autor:
Katarzyna Krupa, Bernard D Naughton, David Brindley, Damian Swieczkowski, Miłosz Jaguszewski, Piotr Merks, Mariola Drozd, Michal Byliniak
Publikováno v:
European Journal of Hospital Pharmacy. Science and Practice
By February 2019, the Polish pharmaceutical industry, community and hospital pharmacies, wholesalers and parallel traders must all comply with the EU-wide Falsified Medicines Directive (FMD) legislation (2011/62/EU), to ensure that no medicinal produ
Publikováno v:
BMJ Open
OBJECTIVES: To identify the authentication and detection rate of serialised medicines using medicines authentication technology. DESIGN AND INTERVENTION: 4192 serialised medicines were entered into a hospital dispensary over two separate 8-week stage
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8cd608597fe4841fc1c9abc1ed0036b8
Autor:
Sue Dopson, James A. Smith, Benjamin Davies, A Ramakrishnan, Asif Ali, S Raza, David Brindley, David Pettitt, Georg A. Holländer, Bernard D Naughton, A Roscoe
Introduction: The Quality Adjusted Life Year (QALY) is a recognised metric used to evaluate new and innovative healthcare treatments and optimise resource allocation via rational and explicit methodologies. This review examines present limitations of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::06529f87a932d29b20a7536e18857675
https://doi.org/10.4172/2157-7633.1000334
https://doi.org/10.4172/2157-7633.1000334
Publikováno v:
European Journal of Hospital Pharmacy. Science and Practice
Sustained growth of falsified and counterfeit medicines in the legal supply chain is a critical threat to patients, (bio)pharmaceutical companies, caregivers, payers and pharmacists.1 ,2 The European Union (EU) Falsified Medicines Directive (FMD) is
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::df5fa282bb2be64b2d553cf172099f80
https://doi.org/10.1136/ejhpharm-2015-000750
https://doi.org/10.1136/ejhpharm-2015-000750
Autor:
Sue Dopson, James R. Smith, Stephen J. Chapman, B Vadher, G Smith, Bernard D Naughton, David Brindley
Since the publication of the Falsified Medicines Directive in 2011 and the subsequent delegated regulation in February 2016, there has been much discussion surrounding the level of Falsified Medicines Directive compliance required by secondary care i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ee3f3796e7941e82b97ef983ba2ef152
https://ora.ox.ac.uk/objects/uuid:1e7105ce-b1b5-49a0-853e-e49b638e215d
https://ora.ox.ac.uk/objects/uuid:1e7105ce-b1b5-49a0-853e-e49b638e215d